[
  {
    "ts": null,
    "headline": "ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus",
    "summary": "Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.",
    "url": "https://finnhub.io/api/news?id=e3d10cbd64e59a767e6ceb1d1b5c3accf019c9d7f1ebcf7711057b7d471ddbe6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752496140,
      "headline": "ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus",
      "id": 135927614,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.",
      "url": "https://finnhub.io/api/news?id=e3d10cbd64e59a767e6ceb1d1b5c3accf019c9d7f1ebcf7711057b7d471ddbe6"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms",
    "summary": "BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.",
    "url": "https://finnhub.io/api/news?id=2646c0323791384b0dcf8a876999ff2f84310f4ba33f201fb319c6bf12715fdc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752494820,
      "headline": "Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms",
      "id": 135927723,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "BIO surges 4% as the Stilla acquisition fuels the launch of four ddPCR systems, expanding to 400K+ assay offerings.",
      "url": "https://finnhub.io/api/news?id=2646c0323791384b0dcf8a876999ff2f84310f4ba33f201fb319c6bf12715fdc"
    }
  },
  {
    "ts": null,
    "headline": "LRT Capital Management June 2025 Investor Update",
    "summary": "During the month of June the LRT Global Opportunities strategy returned -1.30% net of fees. Year-to-date, the strategy has returned +8.12%. Read more here.",
    "url": "https://finnhub.io/api/news?id=31ac7e1d2cc1ef3249f07f90b4148b8c88fbb0ade4b615bf9ff5f74bc0f61941",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752484200,
      "headline": "LRT Capital Management June 2025 Investor Update",
      "id": 135924985,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1180310643/image_1180310643.jpg?io=getty-c-w1536",
      "related": "COR",
      "source": "SeekingAlpha",
      "summary": "During the month of June the LRT Global Opportunities strategy returned -1.30% net of fees. Year-to-date, the strategy has returned +8.12%. Read more here.",
      "url": "https://finnhub.io/api/news?id=31ac7e1d2cc1ef3249f07f90b4148b8c88fbb0ade4b615bf9ff5f74bc0f61941"
    }
  }
]